Avalyn Pharma Inc. (AVLN)
NASDAQ: AVLN · Real-Time Price · USD
28.63
+0.33 (1.17%)
At close: Jul 20, 2026, 4:00 PM EDT
28.50
-0.13 (-0.45%)
Pre-market: Jul 21, 2026, 6:11 AM EDT
Earnings Call Transcripts
Fiscal Year 2026
-
The company is advancing inhaled therapies for pulmonary fibrosis, aiming to improve tolerability and efficacy over current oral treatments. Key programs are in late-stage clinical trials, with strong long-term data and a robust financial position to support further development and potential market leadership.